Using gene testing to guide treatment for drug-resistant tuberculosis
Part of Immune system & allergy, Infections clinical trials.
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active drug-resistant TB (RR-TB) diagnosed at the study site during the study time period
- Your TB sample tests positive (by culture, smear, or a related lab test) at the study facility
- You plan to stay living in the study area for the study period
- You agree to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
This trial tests whether using results from a detailed sputum (phlegm) test to tailor treatment improves outcomes in people with drug-resistant (rifampicin-resistant) pulmonary TB. It may help you get the most appropriate regimen based on your specific test results.
This study is testing new combinations of drugs to treat tuberculosis (TB) in the lungs. It aims to find a more effective and shorter treatment, and you may benefit from receiving these new drugs while helping advance TB research.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
This trial looks at how tuberculosis bacteria might resist treatment. It studies people who test positive for TB using a GeneXpert test, both in the lungs and other body parts.
This trial tests new combinations of TB medicines for people with active lung TB that is sensitive to standard drugs. It aims to find safer, shorter treatments that work just as well or better than current options.
Hear when a new Drug-resistant Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.